Alumni | Virtual
Timely Topics: Rethinking Menopause — An Evidence-Based Review
12–1 p.m. PST
Menopause is redefining midlife health, yet translating this cultural shift into clinical practice remains a major challenge. Many women still struggle to get clear, accurate information about what to expect — and how best to manage their symptoms.
Join women’s health specialist Amy G. Cantor, M.D., M.P.H., MSCP, FAAFP, for an evidence-based review of perimenopause and menopause. This session provide practical tools for translating current best practices into meaningful clinical conversations.
What we’ll cover:
- Perimenopause and menopause fundamentals
- Recognizing and managing the menopause transition
- What has changed since the Women’s Health Initiative study — current evidence on hormone therapy benefits, risks and timing
- Best practices for hormone therapy, including indications, formulations and individual risk-benefit assessment
- Common clinical questions about the role of hormone therapy in symptom management and long-term health outcomes
- How to normalize menopause conversations and help patients navigate misinformation
About the presenter:
Amy G. Cantor, M.D., M.P.H., MSCP, FAAFP, is a professor of medicine, family medicine and obstetrics and gynecology at OHSU, where she serves as primary care faculty at the OHSU Center for Women’s Health and senior investigator at the Pacific Northwest Evidence-based Practice Center. She has extensive clinical and research expertise in women’s health across the lifespan, with fellowship training in women’s health and certification by the Menopause Society. Dr. Cantor has led and supported several systematic evidence reviews on women’s health and primary care topics on behalf of the USPSTF, PCORI, NIH, AHRQ, VA, Cochrane, and the HRSA-sponsored Women’s Preventive Services Initiative (WPSI). Her research has been used to determine national clinical practice guidelines, health policy, and health care coverage decisions affecting millions of Americans.
Dr. Cantor is nationally recognized for her leadership in women’s health research and evidence synthesis and has served on influential national committees including the USPSTF, the WPSI Advisory Panel, and as Methods Advisor for the Cochrane Fertility Regulation Review Group. In addition to research, Dr. Cantor previously served as the medical director of the Health Evidence Review Commission for the Oregon Health Authority and currently serves as the medical director of evidence-based guidelines for OHSU Health.
